Categories: HardwareMedTechPublic
VNUS markets a minimally invasive medical device to treat venous disease, including venous reflux and vein valve incompetence. VNUS went public in October 2004. (NASDAQ:VNUS).
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.08.2019 | - | $1.5M | - |
Mentions in press and media 3
| Date | Title | Description |
| 28.04.2010 | UPDATE: Entellus Medical taps new CEO, launches sinus dilation device | By Brandon Glenn
It’s been a busy couple of days for Entellus Medical Inc., which hired a new chief executive and launched a new product, the XprESS, to treat chronic sinusitis.
Brian Farley, who has served on the company’s board since 2008... |
| 27.04.2010 | Sinusitis-device firm Entellus Medical hires new CEO | Farley joined VNUS, which developed a catheter-based treatment for venous insufficiency, in 1995 as its first employee. During his time as CEO, the company went public in 2004 and was acquired last year for $440 million by medical-products ... |
| - | Sinusitis-device firm Entellus Medical hires new CEO | Entellus Medical Inc., which is developing a less-invasive therapy to treat chronic sinusitis, has hired a new chief executive.
Brian Farley, who has served on the company’s board since 2008 and previously led VNUS Medical Technologies Inc.... |
Reviews 0
